Prescription drug · ANDA
oxybutynin NDC 68382-256
Oxybutynin chloride 10 mg/1 · Tablet, Film coated, Extended release · Oral · Zydus Pharmaceuticals USA Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68382-256-01 | 68382025601 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382-256-01)Marketed from Aug 10, 2017 | |
| 68382-256-05 | 68382025605 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382-256-05)Marketed from Aug 10, 2017 | |
| 68382-256-06 | 68382025606 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382-256-06)Marketed from Aug 10, 2017 | |
| 68382-256-14 | 68382025614 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382-256-14)Marketed from Aug 10, 2017 | |
| 68382-256-16 | 68382025616 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382-256-16)Marketed from Aug 10, 2017 | |
| 68382-256-77 | 68382025677 | 10 BLISTER PACK in 1 CARTON (68382-256-77) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (68382-256-30)Marketed from Aug 10, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- oxybutynin
- Generic name (nonproprietary)
- oxybutynin
- Active ingredients
- Oxybutynin chloride — 10 mg/1
- Dosage form
- Tablet, Film coated, Extended release
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 202332
- Marketing start
- Listing expires
- Other FDA classes
- Cholinergic Muscarinic Antagonists (Mechanism)
- Identifiers
- Product ID 68382-256_f54e4d4e-91be-4e10-a446-57ed5e1843a1SPL ID f54e4d4e-91be-4e10-a446-57ed5e1843a1SPL set ID c042bf06-79a3-4dc7-ae05-3ef3cfae9d44RxCUI 863619, 863628, 863636UNII L9F3D9RENQ
- Pharmacologic class
- Cholinergic Muscarinic Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468382025601followed by a unit qualifier and the quantityPackage 68382-0256-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Oxybutynin chloride is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. ( 1 ) Oxybutynin chloride extended-release tablets are also indicated for the treatment of pediatric patients aged 6 years and older with symptoms of detrusor overactivity associated with a neurological condition (e.g., spina bifida). ( 1 ) Oxybutynin chloride extended-release tablets are a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin chloride extended release tablets are also indicated for the treatment of pediatric patients…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 202332
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| oxybutynin | Oxybutynin chloride 10 mg/1 | Tablet, Film coated, Extended releaseOral | A-S Medication Solutions | 50090-5353 |
| oxybutynin | Oxybutynin chloride 10 mg/1 | Tablet, Film coated, Extended releaseOral | Zydus Lifesciences Limited | 70771-1087 |
| oxybutynin | Oxybutynin chloride 5 mg/1 | Tablet, Film coated, Extended releaseOral | Zydus Lifesciences Limited | 70771-1086 |
| oxybutynin | Oxybutynin chloride 15 mg/1 | Tablet, Film coated, Extended releaseOral | Zydus Lifesciences Limited | 70771-1088 |
| oxybutynin | Oxybutynin chloride 5 mg/1 | Tablet, Film coated, Extended releaseOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8219 |
| oxybutynin | Oxybutynin chloride 10 mg/1 | Tablet, Film coated, Extended releaseOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8220 |
| oxybutynin | Oxybutynin chloride 5 mg/1 | Tablet, Film coated, Extended releaseOral | Zydus Pharmaceuticals USA Inc. | 68382-255 |
| oxybutynin | Oxybutynin chloride 15 mg/1 | Tablet, Film coated, Extended releaseOral | Zydus Pharmaceuticals USA Inc. | 68382-257 |
| oxybutynin | Oxybutynin chloride 5 mg/1 | Tablet, Film coated, Extended releaseOral | Redpharm Drug | 67296-2335 |